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To understand the clinical and epidemiologic charac-
teristics of pandemic (H1N1) 2009 virus infection, we ret-
rospectively reviewed medical records of 237 patients with 
laboratory-conﬁ   rmed cases reported in Shanghai, China, 
during May–July 2009. Surveillance activities effectively 
contained the outbreak and provided useful epidemiologic 
data for future strategies.
I
n early April 2009, human infections caused by pan-
demic (H1N1) 2009 virus were identiﬁ  ed in the United 
States (1) and Mexico (2). The virus then spread rapidly 
around the world. The People’s Republic of China reported 
its ﬁ  rst case of pandemic (H1N1) 2009 on May 10, 2009. 
As of July 31, a total of 2,090 conﬁ  rmed cases had been re-
ported in mainland China. Cases were detected in 25 prov-
inces and municipalities; the largest numbers of cases were 
found in Guangdong Province, Beijing, and Shanghai. To 
understand the clinical and epidemiologic characteristics of 
infected patients, we reviewed medical records of 237 pa-
tients with laboratory-conﬁ  rmed cases reported in Shang-
hai during May–July 2009.
The Study
On April 30, 2009, guidelines for surveillance, report-
ing, diagnosis, and treatment of pandemic (H1N1) 2009 
were published by the Ministry of Health of the People’s 
Republic of China (revised May 9) (3). On the basis of 
these guidelines, the Shanghai Bureau of Health issued a 
working document for prevention and control of pandemic 
(H1N1) 2009 in Shanghai.
Brieﬂ  y, ill persons with a temperature >37.5°C were 
asked to visit fever clinics in local general hospitals. A sus-
pected case of pandemic (H1N1) 2009 was deﬁ  ned as 1) 
an inﬂ  uenza-like illness (fever >37.5°C with >1 signs or 
symptoms, including sore throat, cough, runny nose, na-
sal congestion) in a person who had traveled to a country 
where >1 case had been conﬁ  rmed in the past 7 days or 2) 
clinical symptoms or signs of inﬂ  uenza-like illness in a per-
son epidemiologically linked to a patient with conﬁ  rmed 
or suspected infection identiﬁ  ed in the previous 7 days. A 
conﬁ  rmed case was deﬁ  ned as laboratory conﬁ  rmation of 
infection by PCR performed on a nasopharyngeal swab 
specimen at the Shanghai Center for Disease Control and 
Prevention (Shanghai CDC). All suspected cases were re-
quired to be reported to the Shanghai CDC within 24 hours 
after diagnosis.
Nasopharyngeal swabs obtained from patients with 
suspected cases were sent to the Shanghai CDC for detec-
tion of virus. Virus RNA was extracted and tested for all 
inﬂ  uenza types and speciﬁ  c subtypes by using a series of 
PCRs speciﬁ  c for matrix gene sequences of inﬂ  uenza A and 
B viruses. All patients with PCR results positive for pan-
demic (H1N1) 2009 virus were admitted to the Shanghai 
Public Health Clinical Center (SPHCC). We analyzed the 
clinical and epidemiologic features of conﬁ  rmed cases re-
ported in Shanghai during May 24–July 31, 2009.
In China, a national active surveillance system was 
established preemptively for recent travelers to areas af-
fected by pandemic (H1N1) 2009. Thermal scanners were 
installed at all airports to detect fevers in travelers. Health 
questionnaires were administrated to travelers, and on the 
basis of answers to these questionnaires, all asymptomatic 
contacts of patients with suspected and conﬁ  rmed pandem-
ic (H1N1) 2009 were quarantined for 7 days. Symptomatic 
persons from an affected area were asked to visit fever clin-
ics for conﬁ  rmation of infection. Ambulances transported 
persons with suspected pandemic (H1N1) 2009 from air-
ports to hospitals for screening. Health advisories encour-
aged travelers in whom inﬂ  uenza-like symptoms developed 
after arrival in Shanghai to seek medical care.
Shanghai reported its ﬁ  rst case of pandemic (H1N1) 
2009 on May 24, 2009, in a traveler returning from Aus-
tralia. As of July 31, 2009, SPHCC had identiﬁ  ed 237 
conﬁ  rmed cases: 5 in May, 112 in June, and 120 in July 
(Figure 1). The maximum number of conﬁ  rmed cases re-
ported per date of onset (14) occurred on June 28 and July 
7. Epidemiologic investigations suggested that the outbreak 
peaked in Shanghai in late June and early July.
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Figure 1. Daily number of laboratory-conﬁ  rmed cases of pandemic 
(H1N1) 2009 virus infection, Shanghai, China, May 24–July 31, 
2009. Of the 237 case-patients, 129 (54.4%) were male. Me-
dian age of conﬁ  rmed case-patients was 24 years (range 
2–75 years). Eighty-two percent of case-patients were 10–
39 years of age (Figure 2).
Patients were from 15 countries; 64.6% of patients 
were Chinese citizens, 10.1% were Australian citizens, 
5.9% were American citizens, and 5.9% were Indonesian 
citizens. Among the 237 cases, 230 (97.0%) were iden-
tiﬁ  ed as imported (i.e., conﬁ  rmed case in a person with 
recent travel outside mainland China who had arrived in 
China during the surveillance period and had illness onset 
within 7 days after arrival). A total of 115 of these persons 
were from Australia; 36 from the United States; 18 from 
Canada; 11 from Indonesia; 10 from Singapore; 8 from 
the Philippines; 7 from the United Kingdom; 6 from Hong 
Kong; 4 each from Thailand, Taiwan, and South Korea; 2 
each from Argentina and New Zealand; and 1 each from 
Japan, Mexico, and Italy. Seven (3.0%) patients (1 in June 
and 6 in July) contracted pandemic (H1N1) 2009 while 
in Shanghai and showed a clear epidemiologic link to a 
person with imported pandemic (H1N1) 2009. Of 230 im-
ported cases, 124 (53.9%) were identiﬁ  ed in airports upon 
arrival. No secondary cases occurred among hospital staff 
at SPHCC.
The most commonly reported symptoms were fe-
ver or history of fever (94.9%), dry cough (51.5%), sore 
throat (32.9%), runny nose (19.8%), and productive cough 
(18.1%) (Table). Only 2 case-patients (a 58-year-old man 
and a 49-year-old woman) had diarrhea (0.8%). One case-
patient was a pregnant (13 weeks) Australian woman (31 
years of age) in whom fever (>37.8°C) developed on the 
second day after she arrived from Sydney. Seventeen pa-
tients had underlying medical conditions: asthma (3 pa-
tients), obesity (3), allergic rhinitis (2), lymphoma (1), es-
sential hypertension (5), hypothyroidism and hepatitis B 
(1), and gastric ulcer (2).
Of the 237 case-patients, 236 (99.6%) received osel-
tamivir for 5 days; the pregnant woman refused antiviral 
therapy. Of 236 patients treated, 186 (78.5%) received os-
eltamivir within 48 hours after illness onset. Median time 
between onset of symptoms and start of oseltamivir treat-
ment was 2 days (range 1–5 days). All patients had a mild 
illness. As of July 31, all patients had recovered and were 
discharged from the hospital. Mean ± SD length of hospital 
stay was 4.9 ± 1.7 days (range 3–9 days). No severe cases 
or deaths were reported. No patients were reported to have 
complications or to require intubation or oxygen.
Conclusions
Our investigation indicates that the outbreak in Shang-
hai evolved similarly to outbreaks in other regions (4,5). 
The epidemiologic pattern in Shanghai did not differ from 
that in the Americas and Europe (6–8). Pandemic (H1N1) 
2009 virus preferentially infects younger age groups. Most 
patients had mild symptoms and fully recovered within 1 
week.
Clinical responses were favorable among these 237 
case-patients, including 17 with underlying disease. Pa-
tients in this series seemed to beneﬁ  t from early antiviral 
therapy. Early use of oseltamivir may have prevented com-
plications.
Our study indicates that surveillance activities in 
Shanghai identiﬁ  ed a substantial number of cases of pan-
demic (H1N1) 2009 among travelers early in the outbreak. 
The early response strategy in Shanghai has been contain-
ment; many case-patients were identiﬁ  ed quickly after they 
arrived in China. Our data show that containment may 
have had a useful role in the initial phase of the outbreak. 
In Shanghai, patients with inﬂ  uenza were hospitalized for 
isolation purposes. Because the number of inﬂ  uenza cases 
has increased in Shanghai, the quarantine policy has been 
changed; since August 1, 2009, hospitalization for isolation 
purposes has not been mandated.
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Figure 2. Number of laboratory-conﬁ   rmed cases of pandemic 
(H1N1) 2009 virus infection, by age group, Shanghai, China, May 
24−July 31, 2009.
Table. Signs and symptoms in 237 patients with pandemic 
(H1N1) 2009 virus infection, Shanghai, China, May–July, 2009 
Sign or symptom  No. (%) 
>1 symptoms  237 (100) 
Fever or history of fever  225 (94.9) 
Dry cough  122 (51.5) 
Sore throat  78 (32.9) 
Runny nose  47 (19.8) 
Productive cough  43 (18.1) 
Headache 14 (5.9) 
Muscle pain  11 (4.6) 
Altered consciousness  1 (0.4) 
Diarrhea 2 (0.8) 
Joint pain  2 (0.8) Pandemic (H1N1) 2009, Shanghai, China
Cases of pandemic (H1N1) 2009 in Shanghai during 
May–July 2009 were identiﬁ  ed rapidly and treated with os-
eltamivir, resulting in mild illness and absence of deaths. 
As the pandemic evolves, continued investigation is needed 
to describe its epidemiologic and clinical characteristics.
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